SELENIUM SULFIDE

SELENIUM SULFIDE was reported 946 times

SELENIUM SULFIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LACTOBACILLUS TEST POSITIVE 3 0.1429
1 AURICULOTEMPORAL SYNDROME 1 0.1000
2 PRIMARY PULMONARY MELANOMA 1 0.0769
3 TROUSSEAU'S SYNDROME 2 0.0714
4 MODERATE MENTAL RETARDATION 1 0.0714
5 CHOROID NEOPLASM 1 0.0556
6 LARYNGOSCOPY 1 0.0476
7 DRY SOCKET 1 0.0455
8 FACTOR VIII ACTIVITY DECREASED 1 0.0435
9 DECREASED EMBRYO VIABILITY 1 0.0417
10 FRONTAL SINUS OPERATION 1 0.0357
11 DIHYDROTESTOSTERONE INCREASED 1 0.0345
12 BRONCHIAL ULCERATION 1 0.0250
13 ENDOMETRIAL CANCER STAGE II 1 0.0233
14 CHEMICAL BURNS OF EYE 6 0.0216
15 CORONARY BYPASS THROMBOSIS 1 0.0213
16 MASTOID EFFUSION 1 0.0200
17 ALOPECIA EFFLUVIUM 1 0.0196
18 MUCOSAL MEMBRANE HYPERPLASIA 1 0.0182
19 BRONCHIAL INJURY 1 0.0172
20 APPLICATION SITE BRUISING 1 0.0164
21 MYOCARDIAL BRIDGING 1 0.0156
22 BURSA INJURY 1 0.0154
23 LACTOBACILLUS INFECTION 2 0.0122
24 EXERCISE ELECTROCARDIOGRAM ABNORMAL 1 0.0120
25 LYMPHATIC OBSTRUCTION 1 0.0116
26 BIOPSY BREAST ABNORMAL 1 0.0105
27 COGNITIVE DETERIORATION 1 0.0103
28 HAIR INJURY 3 0.0101
29 FUNDOSCOPY ABNORMAL 1 0.0096
30 CEREBRAL VASCULAR OCCLUSION 1 0.0087
31 BREAST MICROCALCIFICATION 1 0.0083
32 PUS IN STOOL 1 0.0079
33 CUTIS LAXA 2 0.0074
34 HELICOBACTER PYLORI IDENTIFICATION TEST POSITIVE 1 0.0070
35 PICA 1 0.0056
36 OPTIC DISC DISORDER 1 0.0048
37 EXPOSURE VIA EYE CONTACT 2 0.0048
38 MUSCLE OEDEMA 1 0.0046
39 HAIR COLOUR CHANGES 55 0.0044
40 CARDIAC PERFORATION 1 0.0043
41 LACRIMATION DECREASED 2 0.0042
42 INJECTION SITE NERVE DAMAGE 1 0.0042
43 APPLICATION SITE BLEEDING 1 0.0040
44 PATIENT DISSATISFACTION WITH DEVICE 1 0.0040
45 CULTURE WOUND POSITIVE 1 0.0038
46 DEPOSIT EYE 1 0.0037
47 DANDRUFF 8 0.0036
48 BINOCULAR EYE MOVEMENT DISORDER 1 0.0035
49 SEBORRHOEA 12 0.0033
50 MITRAL VALVE REPAIR 1 0.0031
51 POST PROCEDURAL CONTUSION 1 0.0030
52 DRUG EFFECT FASTER THAN EXPECTED 1 0.0030
53 CATARACT NUCLEAR 2 0.0030
54 ORAL SOFT TISSUE DISORDER 1 0.0030
55 BLOOD TRIGLYCERIDES DECREASED 1 0.0030
56 PULMONARY NECROSIS 1 0.0029
57 RETINAL PIGMENT EPITHELIAL TEAR 2 0.0029
58 PRODUCT ODOUR ABNORMAL 30 0.0029
59 RETINAL PIGMENTATION 2 0.0025
60 PRODUCT COLOUR ISSUE 13 0.0025
61 SEBORRHOEIC DERMATITIS 4 0.0024
62 BONE FISSURE 1 0.0024
63 PHLEBITIS SUPERFICIAL 1 0.0024
64 BLOOD HOMOCYSTEINE INCREASED 1 0.0023
65 HAIR TEXTURE ABNORMAL 31 0.0023
66 SKIN ODOUR ABNORMAL 9 0.0023
67 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 2 0.0022
68 POST THROMBOTIC SYNDROME 1 0.0022
69 BANKRUPTCY 1 0.0022
70 POST INFLAMMATORY PIGMENTATION CHANGE 1 0.0022
71 PLICATED TONGUE 1 0.0021
72 LEUKOPLAKIA ORAL 1 0.0019
73 KELOID SCAR 1 0.0019
74 LIGAMENT PAIN 1 0.0019
75 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 1 0.0019
76 BONE DEMINERALISATION 2 0.0019
77 PATHOLOGICAL GAMBLING 3 0.0018
78 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1 0.0018
79 TRICHORRHEXIS 5 0.0018
80 JUGULAR VEIN DISTENSION 1 0.0018
81 CHEMICAL BURN 2 0.0017
82 LUMBAR RADICULOPATHY 2 0.0017
83 MEAN PLATELET VOLUME INCREASED 1 0.0017
84 PARKINSONIAN GAIT 1 0.0016
85 LIVING IN RESIDENTIAL INSTITUTION 3 0.0016
86 GLOMERULOSCLEROSIS 1 0.0016
87 OESOPHAGEAL ACHALASIA 1 0.0016
88 PURULENCE 3 0.0015
89 PRESSURE OF SPEECH 1 0.0015
90 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
91 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
92 MYOFASCIAL PAIN SYNDROME 1 0.0014
93 PRODUCT FORMULATION ISSUE 9 0.0014
94 BASOPHIL COUNT INCREASED 1 0.0013
95 CHROMATOPSIA 1 0.0013
96 COAGULATION TEST ABNORMAL 1 0.0013
97 ASEPTIC NECROSIS BONE 1 0.0013
98 PUSTULE 3 0.0013
99 LIP ERYTHEMA 1 0.0013
100 EROSIVE DUODENITIS 1 0.0013
101 ENDOMETRIAL HYPERPLASIA 1 0.0012
102 CHEMICAL INJURY 1 0.0012
103 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
104 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
105 BALANOPOSTHITIS 1 0.0012
106 OCULAR VASCULAR DISORDER 1 0.0012
107 PERITONSILLAR ABSCESS 1 0.0012
108 SKIN WOUND 2 0.0012
109 ENDOCRINE OPHTHALMOPATHY 1 0.0012
110 PRODUCT PHYSICAL CONSISTENCY ISSUE 6 0.0011
111 PRODUCT APPEARANCE CONFUSION 1 0.0011
112 DYSENTERY 2 0.0011
113 APPLICATION SITE DERMATITIS 1 0.0011
114 MICROANGIOPATHY 1 0.0011
115 FACIAL ASYMMETRY 1 0.0010
116 GINGIVAL RECESSION 2 0.0010
117 APPLICATION SITE BRUISE 1 0.0010
118 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
119 BLOOD IMMUNOGLOBULIN M DECREASED 1 0.0010
120 REBOUND ACID HYPERSECRETION 3 0.0010
121 THROMBOPHLEBITIS SUPERFICIAL 3 0.0010
122 PRODUCT CLOSURE REMOVAL DIFFICULT 1 0.0010
123 CAROTID ARTERIOSCLEROSIS 1 0.0010
124 BONE MARROW OEDEMA 1 0.0010
125 VITREOUS DETACHMENT 2 0.0009
126 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
127 RHINITIS ALLERGIC 4 0.0009
128 APPLICATION SITE DRYNESS 3 0.0009
129 PO2 DECREASED 1 0.0009
130 FOLATE DEFICIENCY 1 0.0009
131 DILATATION ATRIAL 1 0.0009
132 BREATH ODOUR 2 0.0008
133 APPLICATION SITE BURN 4 0.0008
134 MALIGNANT MELANOMA IN SITU 1 0.0008
135 FRACTURED SACRUM 1 0.0008
136 CUTANEOUS T-CELL LYMPHOMA 1 0.0008
137 RETINAL ARTERY OCCLUSION 2 0.0008
138 NEPHRITIS INTERSTITIAL 1 0.0008
139 CHEMICAL BURN OF SKIN 2 0.0008
140 COMMUNICATION DISORDER 3 0.0008
141 RETINAL DISORDER 2 0.0008
142 POSTPARTUM HAEMORRHAGE 1 0.0007
143 DRUG EFFECT LESS THAN EXPECTED 11 0.0007
144 BODY MASS INDEX INCREASED 1 0.0007
145 CARBON DIOXIDE INCREASED 1 0.0007
146 CORNEAL OPACITY 1 0.0007
147 EFFUSION 1 0.0007
148 ORAL FUNGAL INFECTION 2 0.0007
149 CORNEAL ABRASION 1 0.0007
150 IMMUNOGLOBULINS DECREASED 1 0.0007
151 H1N1 INFLUENZA 1 0.0007
152 ALVEOLITIS 1 0.0007
153 CATAPLEXY 1 0.0007
154 LOW DENSITY LIPOPROTEIN DECREASED 1 0.0007
155 CONNECTIVE TISSUE DISORDER 1 0.0007
156 PELVIC VENOUS THROMBOSIS 1 0.0007
157 ABNORMAL SENSATION IN EYE 3 0.0007
158 DIABETES MELLITUS NON-INSULIN-DEPENDENT 1 0.0007
159 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
160 PANCREATIC ENZYMES INCREASED 1 0.0007
161 PRECANCEROUS SKIN LESION 1 0.0007
162 SENSITIVE SKIN 5 0.0007
163 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
164 GENITAL PAIN 1 0.0007
165 AGE-RELATED MACULAR DEGENERATION 1 0.0007
166 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
167 POLYCYSTIC OVARIES 1 0.0006
168 OSTEOSCLEROSIS 1 0.0006
169 CHRONIC LYMPHOCYTIC LEUKAEMIA 3 0.0006
170 INTERMITTENT CLAUDICATION 1 0.0006
171 HISTOPLASMOSIS DISSEMINATED 1 0.0006
172 NIGHT BLINDNESS 1 0.0006
173 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
174 COSTOCHONDRITIS 1 0.0006
175 OPTIC ATROPHY 1 0.0006
176 BACTERIAL SEPSIS 2 0.0006
177 STOMACH DISCOMFORT 3 0.0006
178 CERVICAL SPINAL STENOSIS 1 0.0006
179 BLOOD CHLORIDE INCREASED 1 0.0006
180 DEPRESSION SUICIDAL 2 0.0006
181 OTORRHOEA 1 0.0006
182 FANCONI SYNDROME ACQUIRED 1 0.0006
183 PHARYNGOLARYNGEAL PAIN 3 0.0006
184 MACULOPATHY 2 0.0006
185 JUGULAR VEIN THROMBOSIS 1 0.0006
186 APPLICATION SITE DISCOMFORT 1 0.0006
187 MONOCYTE COUNT INCREASED 2 0.0006
188 ESSENTIAL HYPERTENSION 1 0.0005
189 CONTRAST MEDIA ALLERGY 1 0.0005
190 CONDUCTION DISORDER 1 0.0005
191 PUPILLARY REFLEX IMPAIRED 1 0.0005
192 SNORING 2 0.0005
193 PERONEAL NERVE PALSY 3 0.0005
194 ECONOMIC PROBLEM 8 0.0005
195 GUN SHOT WOUND 1 0.0005
196 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
197 SKIN WARM 3 0.0005
198 URINE ODOUR ABNORMAL 3 0.0005
199 PROSTATOMEGALY 2 0.0005
200 NAIL DISCOLOURATION 2 0.0005
201 OESOPHAGEAL PAIN 2 0.0005
202 CORONARY ARTERY THROMBOSIS 1 0.0005
203 LIBIDO INCREASED 1 0.0005
204 DIVERTICULAR PERFORATION 1 0.0005
205 HAIR DISORDER 4 0.0005
206 LIVEDO RETICULARIS 1 0.0005
207 APPLICATION SITE SCAB 1 0.0005
208 APPLICATION SITE VESICLES 3 0.0005
209 TONGUE DISCOLOURATION 2 0.0005
210 PERICARDIAL HAEMORRHAGE 1 0.0005
211 BIPOLAR I DISORDER 1 0.0005
212 ENDOMETRIAL CANCER 1 0.0005
213 NOSOCOMIAL INFECTION 1 0.0005
214 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
215 PARESIS 1 0.0004
216 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
217 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
218 LICHENOID KERATOSIS 1 0.0004
219 PATELLA FRACTURE 1 0.0004
220 DISCOURAGEMENT 1 0.0004
221 FLANK PAIN 4 0.0004
222 SKIN ABRASION 2 0.0004
223 RETINAL HAEMORRHAGE 3 0.0004
224 CARDIAC TAMPONADE 2 0.0004
225 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
226 PULSE ABNORMAL 1 0.0004
227 BRONCHITIS CHRONIC 1 0.0004
228 CORONARY ARTERY STENOSIS 2 0.0004
229 EXPOSURE VIA INGESTION 1 0.0004
230 LABYRINTHITIS 1 0.0004
231 DYSLIPIDAEMIA 2 0.0004
232 ACTINIC KERATOSIS 1 0.0004
233 END STAGE RENAL DISEASE 7 0.0004
234 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
235 HYPERSENSITIVITY VASCULITIS 1 0.0004
236 RADICULOPATHY 1 0.0004
237 INCONTINENCE 4 0.0004
238 PRODUCT CLEANING INADEQUATE 1 0.0004
239 OBSESSIVE-COMPULSIVE DISORDER 3 0.0004
240 GAMBLING DISORDER 1 0.0004
241 BEHAVIOUR DISORDER 2 0.0004
242 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
243 BLOOD PHOSPHORUS INCREASED 1 0.0004
244 HYPERAESTHESIA 3 0.0004
245 STREPTOCOCCAL INFECTION 2 0.0004
246 LUNG CONSOLIDATION 1 0.0004
247 INFUSION SITE ERYTHEMA 3 0.0004
248 DERMATITIS CONTACT 4 0.0004
249 PRODUCT CONTAINER ISSUE 3 0.0003
250 HEART VALVE INCOMPETENCE 1 0.0003
251 LIP PAIN 1 0.0003
252 PHARYNGEAL DISORDER 1 0.0003
253 MACULAR DEGENERATION 4 0.0003
254 HYPERLIPIDAEMIA 4 0.0003
255 EMERGENCY CARE 1 0.0003
256 EMBOLISM VENOUS 1 0.0003
257 EYE INJURY 1 0.0003
258 PENILE PAIN 1 0.0003
259 DYSAESTHESIA 1 0.0003
260 BRAIN DEATH 1 0.0003
261 SCOLIOSIS 2 0.0003
262 APPLICATION SITE IRRITATION 4 0.0003
263 APPLICATION SITE PAIN 7 0.0003
264 INFUSION SITE PRURITUS 1 0.0003
265 PNEUMONIA VIRAL 1 0.0003
266 LOOSE TOOTH 1 0.0003
267 POSTURE ABNORMAL 1 0.0003
268 LYMPHOCYTE COUNT INCREASED 1 0.0003
269 SKIN IRRITATION 14 0.0003
270 DEAFNESS NEUROSENSORY 1 0.0003
271 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
272 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
273 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
274 PEPTIC ULCER 1 0.0003
275 LYME DISEASE 1 0.0003
276 ANXIETY DISORDER 1 0.0003
277 TOXIC SKIN ERUPTION 3 0.0003
278 METASTASES TO SPINE 1 0.0003
279 THERAPEUTIC RESPONSE DECREASED 18 0.0003
280 SCAR 5 0.0003
281 CORONARY ARTERY OCCLUSION 4 0.0003
282 LEFT VENTRICULAR FAILURE 1 0.0003
283 HAIR GROWTH ABNORMAL 2 0.0003
284 HYPERREFLEXIA 1 0.0003
285 CAROTID ARTERY STENOSIS 1 0.0003
286 EAR PRURITUS 1 0.0003
287 HANGOVER 1 0.0003
288 LOGORRHOEA 1 0.0003
289 JAUNDICE CHOLESTATIC 1 0.0003
290 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
291 THERMAL BURN 2 0.0003
292 NO ADVERSE EVENT 51 0.0003
293 HAEMORRHAGIC DIATHESIS 1 0.0003
294 APPENDICECTOMY 1 0.0003
295 VISUAL FIELD DEFECT 2 0.0003
296 ASPIRATION 3 0.0003
297 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
298 HYPOMANIA 1 0.0003
299 HYPOPHOSPHATAEMIA 2 0.0003
300 SKIN HAEMORRHAGE 4 0.0003
301 BONE DENSITY ABNORMAL 1 0.0003
302 CHRONIC SINUSITIS 1 0.0003
303 ANHEDONIA 7 0.0003
304 BREAST TENDERNESS 2 0.0003
305 PROTEIN TOTAL DECREASED 1 0.0003
306 PAROSMIA 2 0.0003
307 PARANASAL SINUS DISCOMFORT 1 0.0003
308 LOSS OF CONTROL OF LEGS 1 0.0003
309 MYOCARDIAL ISCHAEMIA 3 0.0003
310 OSTEOPENIA 4 0.0003
311 FACE INJURY 1 0.0003
312 SCAB 3 0.0003
313 SLEEP APNOEA SYNDROME 5 0.0003
314 DEVICE RELATED INFECTION 4 0.0003
315 OESOPHAGEAL DISORDER 1 0.0003
316 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
317 SPINAL PAIN 3 0.0003
318 EPIGASTRIC DISCOMFORT 1 0.0003
319 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
320 RENAL CYST 2 0.0003
321 CEREBRAL ATROPHY 1 0.0003
322 HYPERPHAGIA 1 0.0003
323 CANDIDIASIS 1 0.0002
324 SKIN EXFOLIATION 21 0.0002
325 SENSORY LOSS 2 0.0002
326 FRUSTRATION TOLERANCE DECREASED 2 0.0002
327 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
328 APPLICATION SITE DISCOLOURATION 1 0.0002
329 ESCHERICHIA INFECTION 2 0.0002
330 ILEUS 3 0.0002
331 CONGESTIVE CARDIOMYOPATHY 1 0.0002
332 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
333 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
334 ONYCHOMADESIS 1 0.0002
335 UTERINE PERFORATION 2 0.0002
336 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
337 CARDIAC FAILURE CHRONIC 1 0.0002
338 INTERVERTEBRAL DISC DISORDER 1 0.0002
339 PURULENT DISCHARGE 1 0.0002
340 HIATUS HERNIA 3 0.0002
341 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
342 LOCAL SWELLING 4 0.0002
343 MELANOCYTIC NAEVUS 1 0.0002
344 SPINAL OSTEOARTHRITIS 2 0.0002
345 CATHETERISATION CARDIAC 1 0.0002
346 CHRONIC KIDNEY DISEASE 17 0.0002
347 QUALITY OF LIFE DECREASED 3 0.0002
348 IRON DEFICIENCY 1 0.0002
349 PERIPHERAL COLDNESS 3 0.0002
350 ISCHAEMIA 1 0.0002
351 UROSEPSIS 2 0.0002
352 IRON DEFICIENCY ANAEMIA 2 0.0002
353 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
354 LOCALISED OEDEMA 1 0.0002
355 NEPHROGENIC ANAEMIA 1 0.0002
356 SKIN REACTION 3 0.0002
357 BLOOD PROLACTIN INCREASED 1 0.0002
358 SPUTUM DISCOLOURED 2 0.0002
359 EXPIRED PRODUCT ADMINISTERED 7 0.0002
360 ALOPECIA 41 0.0002
361 ATELECTASIS 2 0.0002
362 LIVER INJURY 5 0.0002
363 NASAL POLYPS 1 0.0002
364 EXPIRED DRUG ADMINISTERED 1 0.0002
365 ABDOMINAL TENDERNESS 1 0.0002
366 APPLICATION SITE SWELLING 1 0.0002
367 DRUG TOLERANCE 1 0.0002
368 PHLEBITIS 1 0.0002
369 FEMORAL NECK FRACTURE 1 0.0002
370 ENDOCARDITIS 1 0.0002
371 CACHEXIA 1 0.0002
372 CEREBRAL ISCHAEMIA 1 0.0002
373 PERIPHERAL VASCULAR DISORDER 1 0.0002
374 TOOTH LOSS 4 0.0002
375 PETECHIAE 2 0.0002
376 BLOOD LACTIC ACID INCREASED 1 0.0002
377 SCRATCH 2 0.0002
378 LEARNING DISABILITY 1 0.0002
379 RETCHING 4 0.0002
380 SENSORY DISTURBANCE 3 0.0002
381 COMPRESSION FRACTURE 1 0.0002
382 OVERWEIGHT 1 0.0002
383 ANAL ABSCESS 1 0.0002
384 PRODUCT RESIDUE PRESENT 1 0.0002
385 CHEILITIS 1 0.0002
386 PRODUCT PRESCRIBING ISSUE 4 0.0002
387 BLOOD GLUCOSE FLUCTUATION 2 0.0002
388 FAECALOMA 1 0.0002
389 CHOKING SENSATION 1 0.0002
390 DENTAL CARIES 2 0.0002
391 NECROSIS 1 0.0002
392 INTRACRANIAL PRESSURE INCREASED 1 0.0002
393 BLOOD CALCIUM DECREASED 2 0.0002
394 PERIORBITAL SWELLING 1 0.0002
395 IMPAIRED DRIVING ABILITY 2 0.0002
396 GRANULOCYTOPENIA 1 0.0002
397 MICTURITION URGENCY 2 0.0002
398 CHOLECYSTECTOMY 2 0.0002
399 HYPERVENTILATION 1 0.0002
400 ORTHOSTATIC HYPOTENSION 3 0.0002
401 PRODUCT LABEL CONFUSION 1 0.0002
402 ENERGY INCREASED 1 0.0002
403 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
404 RENAL INJURY 5 0.0002
405 SKIN BURNING SENSATION 12 0.0002
406 GASTROENTERITIS VIRAL 3 0.0002
407 BURSITIS 2 0.0002
408 NOCTURIA 2 0.0002
409 DERMATITIS ACNEIFORM 1 0.0002
410 CHOLANGITIS 1 0.0002
411 OLIGURIA 1 0.0002
412 AGEUSIA 4 0.0002
413 PRE-EXISTING CONDITION IMPROVED 1 0.0002
414 PNEUMONIA ASPIRATION 4 0.0002
415 INFUSION SITE SWELLING 1 0.0002
416 PRURITUS 61 0.0002
417 BRAIN OEDEMA 2 0.0002
418 GASTRIC ULCER 3 0.0002
419 PROTEINURIA 3 0.0002
420 POST PROCEDURAL COMPLICATION 3 0.0002
421 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
422 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
423 ANOREXIA 2 0.0002
424 ERUCTATION 3 0.0002
425 HEPATITIS ACUTE 1 0.0002
426 POLYP 1 0.0002
427 APPLICATION SITE ERYTHEMA 4 0.0002
428 DYSGRAPHIA 1 0.0002
429 IMMUNE SYSTEM DISORDER 2 0.0002
430 TOOTH INFECTION 2 0.0002
431 SARS-COV-2 TEST POSITIVE 2 0.0002
432 CORONAVIRUS INFECTION 1 0.0002
433 SKIN DISORDER 5 0.0001
434 MENINGITIS 1 0.0001
435 POST-TRAUMATIC STRESS DISORDER 1 0.0001
436 PAIN OF SKIN 4 0.0001
437 PRODUCT ADMINISTRATION ERROR 3 0.0001
438 BRONCHIECTASIS 1 0.0001
439 TASTE DISORDER 3 0.0001
440 PRODUCT LABEL ISSUE 1 0.0001
441 BLINDNESS 6 0.0001
442 IMPAIRED GASTRIC EMPTYING 2 0.0001
443 AKATHISIA 2 0.0001
444 GINGIVAL BLEEDING 2 0.0001
445 APPLICATION SITE RASH 2 0.0001
446 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
447 JOINT EFFUSION 1 0.0001
448 DROOLING 1 0.0001
449 LYMPHOEDEMA 1 0.0001
450 LARGE INTESTINE PERFORATION 1 0.0001
451 ORAL DISCOMFORT 2 0.0001
452 EXTRASYSTOLES 1 0.0001
453 METASTASIS 1 0.0001
454 FAECES DISCOLOURED 3 0.0001
455 LIVER FUNCTION TEST ABNORMAL 4 0.0001
456 FAECES SOFT 1 0.0001
457 MAJOR DEPRESSION 1 0.0001
458 DYSPHONIA 8 0.0001
459 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
460 BLINDNESS TRANSIENT 1 0.0001
461 PSYCHIATRIC SYMPTOM 1 0.0001
462 TOOTH DISORDER 3 0.0001
463 DRY SKIN 18 0.0001
464 FEELING DRUNK 1 0.0001
465 BONE LOSS 2 0.0001
466 DYSPNOEA EXERTIONAL 5 0.0001
467 PEMPHIGOID 1 0.0001
468 LACRIMATION INCREASED 4 0.0001
469 PLEURAL EFFUSION 8 0.0001
470 AORTIC ANEURYSM 1 0.0001
471 ACIDOSIS 1 0.0001
472 LIPASE INCREASED 1 0.0001
473 PERICARDIAL EFFUSION 3 0.0001
474 FOOD ALLERGY 1 0.0001
475 LYMPHOMA 2 0.0001
476 TENDONITIS 2 0.0001
477 HYPOALBUMINAEMIA 1 0.0001
478 BONE DENSITY DECREASED 4 0.0001
479 MULTIPLE ALLERGIES 1 0.0001
480 HAEMATOCHEZIA 7 0.0001
481 DRUG SCREEN POSITIVE 1 0.0001
482 ABNORMAL BEHAVIOUR 5 0.0001
483 OBESITY 2 0.0001
484 MULTIPLE SCLEROSIS 6 0.0001
485 DYSKINESIA 5 0.0001
486 OSTEONECROSIS 4 0.0001
487 MULTIPLE FRACTURES 2 0.0001
488 VISUAL ACUITY REDUCED 4 0.0001
489 POLLAKIURIA 5 0.0001
490 CELLULITIS 6 0.0001
491 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
492 CONDITION AGGRAVATED 36 0.0001
493 HEPATITIS 3 0.0001
494 PSEUDOMONAS INFECTION 1 0.0001
495 SKIN ULCER 3 0.0001
496 PARANOIA 2 0.0001
497 BLOOD MAGNESIUM DECREASED 1 0.0001
498 PSYCHOLOGICAL TRAUMA 1 0.0001
499 CARDIAC MURMUR 1 0.0001
500 HYSTERECTOMY 1 0.0001
501 GRIP STRENGTH DECREASED 1 0.0001
502 HYPOXIA 4 0.0001
503 LUNG INFILTRATION 1 0.0001
504 ATRIAL FIBRILLATION 11 0.0001
505 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
506 MYOSITIS 1 0.0001
507 BLOOD BILIRUBIN INCREASED 3 0.0001
508 FREQUENT BOWEL MOVEMENTS 3 0.0001
509 DEVELOPMENTAL DELAY 1 0.0001
510 LEUKOCYTOSIS 2 0.0001
511 TOOTHACHE 2 0.0001
512 LIMB INJURY 3 0.0001
513 CRYING 4 0.0001
514 RESTLESS LEGS SYNDROME 2 0.0001
515 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
516 INCREASED TENDENCY TO BRUISE 1 0.0001
517 GRAND MAL CONVULSION 1 0.0001
518 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
519 CONJUNCTIVITIS 2 0.0001
520 FEELING COLD 3 0.0001
521 AMNESIA 7 0.0001
522 BACTERIAL INFECTION 2 0.0001
523 MIDDLE INSOMNIA 2 0.0001
524 APPENDICITIS 1 0.0001
525 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
526 TARDIVE DYSKINESIA 3 0.0001
527 PHOTOPHOBIA 2 0.0001
528 ARTERIOSCLEROSIS 1 0.0001
529 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
530 FOOT FRACTURE 2 0.0001
531 BLOOD URINE PRESENT 2 0.0001
532 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
533 EYE IRRITATION 6 0.0001
534 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
535 HYPERCHOLESTEROLAEMIA 1 0.0001
536 DIZZINESS POSTURAL 1 0.0001
537 AUTOIMMUNE DISORDER 1 0.0001
538 HAEMORRHOIDS 2 0.0001
539 HEPATOMEGALY 1 0.0001
540 SPINAL FRACTURE 2 0.0001
541 PRODUCT PHYSICAL ISSUE 2 0.0001
542 EMPHYSEMA 1 0.0001
543 EMOTIONAL DISTRESS 12 0.0001
544 CORONARY ARTERY DISEASE 3 0.0001
545 INTENTIONAL SELF-INJURY 2 0.0001
546 HYPOTHERMIA 1 0.0001
547 DRUG LEVEL DECREASED 1 0.0001
548 NEUTROPHIL COUNT INCREASED 1 0.0001
549 EAR DISCOMFORT 1 0.0001
550 LIMB DISCOMFORT 3 0.0001
551 HYPERBILIRUBINAEMIA 1 0.0001
552 SWOLLEN TONGUE 3 0.0001
553 DRUG INEFFECTIVE 126 0.0001
554 RENAL IMPAIRMENT 8 0.0001
555 INJECTION SITE DISCOMFORT 1 0.0001
556 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
557 ANXIETY 27 0.0001
558 HEAD INJURY 3 0.0001
559 JOINT INJURY 2 0.0001
560 BODY HEIGHT DECREASED 1 0.0001
561 NIGHT SWEATS 3 0.0001
562 HALLUCINATION 7 0.0001
563 DECREASED ACTIVITY 1 0.0001
564 UNEVALUABLE EVENT 7 0.0001
565 ACNE 7 0.0001
566 BIPOLAR DISORDER 1 0.0001
567 PULMONARY THROMBOSIS 1 0.0001
568 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
569 EYE DISORDER 3 0.0001
570 MELAENA 2 0.0001
571 INJECTION SITE NODULE 1 0.0001
572 VIRAL INFECTION 3 0.0001
573 URINARY RETENTION 3 0.0001
574 OCULAR DISCOMFORT 1 0.0001
575 ANGER 3 0.0001
576 CHROMATURIA 2 0.0001
577 EYE INFECTION 1 0.0001
578 HEART RATE IRREGULAR 2 0.0001
579 MITRAL VALVE INCOMPETENCE 1 0.0001
580 FLATULENCE 5 0.0001
581 APPLICATION SITE PRURITUS 2 0.0001
582 HAEMATURIA 3 0.0001
583 MYOCARDITIS 1 0.0001
584 NEOPLASM 1 0.0001
585 LETHARGY 5 0.0001
586 GASTRIC HAEMORRHAGE 1 0.0001
587 HYPOKALAEMIA 4 0.0001
588 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
589 DRY MOUTH 7 0.0001
590 MADAROSIS 1 0.0001
591 POST PROCEDURAL HAEMORRHAGE 1 0.0001
592 BURNING SENSATION 6 0.0001
593 SURGERY 5 0.0001
594 COVID-19 PNEUMONIA 1 0.0001
595 SOMNOLENCE 17 0.0001
596 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
597 BACTERAEMIA 1 0.0001
598 ATAXIA 1 0.0001
599 COMA 4 0.0001
600 CHOLECYSTITIS 1 0.0001
601 HEPATITIS C 1 0.0001
602 CONSTIPATION 18 0.0001
603 PANIC ATTACK 3 0.0001
604 FIBROMYALGIA 2 0.0001
605 PRESYNCOPE 2 0.0001
606 NEURALGIA 2 0.0001
607 UNDERDOSE 6 0.0001
608 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
609 MUSCLE SPASTICITY 1 0.0001
610 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
611 CARDIOMEGALY 1 0.0001
612 HYPERCALCAEMIA 1 0.0001
613 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0001
614 CYST 1 0.0001
615 DYSARTHRIA 3 0.0001
616 DERMATITIS ALLERGIC 1 0.0001
617 ABDOMINAL PAIN LOWER 2 0.0001
618 HAEMATEMESIS 2 0.0001
619 INTRAOCULAR PRESSURE INCREASED 1 0.0001
620 HYPOPHAGIA 2 0.0001
621 INFUSION SITE PAIN 1 0.0001
622 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
623 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
624 DEEP VEIN THROMBOSIS 5 0.0001
625 RESPIRATORY TRACT INFECTION 2 0.0001
626 PLATELET COUNT INCREASED 1 0.0001
627 NODULE 1 0.0001
628 SEDATION 2 0.0001
629 MUSCLE SPASMS 14 0.0001
630 JOINT STIFFNESS 2 0.0001
631 GASTRITIS 2 0.0001
632 ANKYLOSING SPONDYLITIS 1 0.0001
633 FEAR 2 0.0001
634 OEDEMA PERIPHERAL 9 0.0001
635 HEPATIC ENZYME INCREASED 5 0.0001
636 MOOD ALTERED 2 0.0001
637 OSTEOPOROSIS 3 0.0001
638 SKIN LESION 2 0.0001
639 RESPIRATORY DISTRESS 2 0.0001
640 COORDINATION ABNORMAL 1 0.0001
641 NECK PAIN 4 0.0001
642 MASS 1 0.0001
643 CARPAL TUNNEL SYNDROME 1 0.0001
644 INSOMNIA 19 0.0001
645 BLINDNESS UNILATERAL 1 0.0001
646 EYE PAIN 4 0.0001
647 OSTEOARTHRITIS 3 0.0001
648 CHEST PAIN 13 0.0001
649 BRONCHOSPASM 1 0.0001
650 RED BLOOD CELL COUNT DECREASED 2 0.0001
651 HYPERHIDROSIS 9 0.0001
652 PARALYSIS 1 0.0001
653 RECTAL HAEMORRHAGE 3 0.0001
654 ANGINA PECTORIS 2 0.0001
655 MOBILITY DECREASED 5 0.0001
656 IMPAIRED QUALITY OF LIFE 1 0.0001
657 PSORIASIS 9 0.0001
658 APATHY 1 0.0001
659 GASTROENTERITIS 1 0.0001
660 MUSCULOSKELETAL STIFFNESS 6 0.0001
661 ERYTHEMA 14 0.0001
662 AGITATION 5 0.0001
663 GAIT DISTURBANCE 13 0.0001
664 ACUTE MYOCARDIAL INFARCTION 2 0.0001
665 CARDIOMYOPATHY 1 0.0001
666 DYSGEUSIA 5 0.0001
667 EPISTAXIS 5 0.0001
668 HYPOAESTHESIA 10 0.0001
669 HEPATIC FAILURE 2 0.0001
670 BLOOD COUNT ABNORMAL 1 0.0001
671 DEVICE FAILURE 1 0.0001
672 HIP ARTHROPLASTY 1 0.0001
673 EMOTIONAL DISORDER 2 0.0001
674 GYNAECOMASTIA 2 0.0001
675 MUSCULOSKELETAL CHEST PAIN 1 0.0001
676 ANKLE FRACTURE 1 0.0001
677 FEMUR FRACTURE 2 0.0001
678 WEIGHT DECREASED 18 0.0001
679 EJECTION FRACTION DECREASED 1 0.0001
680 COGNITIVE DISORDER 3 0.0001
681 BASAL CELL CARCINOMA 1 0.0001
682 NERVOUS SYSTEM DISORDER 2 0.0001
683 PARAESTHESIA 10 0.0001
684 PRODUCT USE COMPLAINT 1 0.0001
685 CYSTITIS 2 0.0001
686 RASH ERYTHEMATOUS 3 0.0001
687 HYPOTHYROIDISM 2 0.0001
688 RASH 27 0.0001
689 PAIN 38 0.0001
690 LACTIC ACIDOSIS 2 0.0001
691 MUSCULAR WEAKNESS 7 0.0001
692 BLOOD POTASSIUM INCREASED 1 0.0001
693 LUNG DISORDER 3 0.0001
694 PAIN IN EXTREMITY 18 0.0001
695 CHOLELITHIASIS 2 0.0001
696 METASTASES TO BONE 1 0.0001
697 STAPHYLOCOCCAL INFECTION 2 0.0001
698 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
699 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
700 RENAL FAILURE 8 0.0001
701 CYTOMEGALOVIRUS INFECTION 1 0.0001
702 DRY EYE 3 0.0001
703 LIP SWELLING 2 0.0001
704 COAGULOPATHY 1 0.0001
705 LEUKOPENIA 3 0.0001
706 GAIT INABILITY 2 0.0001
707 CANDIDA INFECTION 1 0.0001
708 HEMIPARESIS 1 0.0001
709 PRODUCT QUALITY ISSUE 8 0.0001
710 ACUTE KIDNEY INJURY 9 0.0001
711 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
712 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
713 INJECTION SITE REACTION 4 0.0001
714 JOINT SWELLING 7 0.0001
715 RASH MACULAR 2 0.0001
716 DEPRESSION 13 0.0001
717 HYPERKALAEMIA 2 0.0001
718 INJURY 4 0.0001
719 DERMATITIS ATOPIC 3 0.0001
720 COLD SWEAT 1 0.0001
721 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
722 LYMPHOCYTE COUNT DECREASED 1 0.0001
723 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
724 HEAD DISCOMFORT 1 0.0001
725 DRUG ERUPTION 1 0.0001
726 BACK PAIN 13 0.0001
727 CONFUSIONAL STATE 9 0.0001
728 ADVERSE DRUG REACTION 5 0.0001
729 DISTURBANCE IN ATTENTION 3 0.0001
730 RASH PRURITIC 3 0.0001
731 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
732 PELVIC PAIN 1 0.0001
733 C-REACTIVE PROTEIN INCREASED 2 0.0001
734 BONE DISORDER 1 0.0001
735 RESPIRATORY FAILURE 4 0.0001
736 HYPOTENSION 11 0.0001
737 DYSURIA 2 0.0001
738 FEELING ABNORMAL 13 0.0001
739 MEDICATION ERROR 3 0.0001
740 AGRANULOCYTOSIS 1 0.0001
741 SEPSIS 6 0.0001
742 HEPATIC STEATOSIS 1 0.0001
743 BREAST CANCER 5 0.0001
744 OXYGEN SATURATION DECREASED 3 0.0001
745 PRODUCT USE ISSUE 10 0.0001
746 VOMITING 25 0.0001
747 HYPOCALCAEMIA 1 0.0001
748 MUSCULOSKELETAL DISORDER 1 0.0001
749 FEELING JITTERY 1 0.0001
750 MIGRAINE 5 0.0001
751 HERPES ZOSTER 3 0.0001
752 PULMONARY FIBROSIS 1 0.0001
753 CHOLESTASIS 1 0.0001
754 DRUG PRESCRIBING ERROR 1 0.0001
755 LOWER LIMB FRACTURE 1 0.0001
756 ACUTE RESPIRATORY FAILURE 1 0.0001
757 DYSTONIA 1 0.0001
758 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
759 BONE PAIN 3 0.0001
760 KIDNEY INFECTION 1 0.0001
761 DISABILITY 1 0.0001
762 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
763 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
764 HAEMATOCRIT DECREASED 1 0.0001
765 BLOOD PRESSURE ABNORMAL 1 0.0001
766 COMPLICATION OF DEVICE INSERTION 1 0.0001
767 PRESCRIBED UNDERDOSE 1 0.0001
768 COUGH 14 0.0000
769 ABORTION SPONTANEOUS 2 0.0000
770 IRRITABILITY 3 0.0000
771 THROMBOSIS 4 0.0000
772 FULL BLOOD COUNT DECREASED 1 0.0000
773 FEEDING DISORDER 1 0.0000
774 PSORIATIC ARTHROPATHY 2 0.0000
775 NEUTROPHIL COUNT DECREASED 2 0.0000
776 FEELING HOT 3 0.0000
777 ABDOMINAL PAIN UPPER 10 0.0000
778 HYPERSENSITIVITY 9 0.0000
779 VISUAL IMPAIRMENT 6 0.0000
780 TREMOR 8 0.0000
781 RHABDOMYOLYSIS 2 0.0000
782 ASTHENIA 18 0.0000
783 CARDIO-RESPIRATORY ARREST 2 0.0000
784 DERMATITIS 1 0.0000
785 MOUTH ULCERATION 1 0.0000
786 HALLUCINATION, VISUAL 1 0.0000
787 ABDOMINAL PAIN 11 0.0000
788 HYPERTENSION 10 0.0000
789 MYALGIA 8 0.0000
790 EATING DISORDER 1 0.0000
791 IMPAIRED WORK ABILITY 1 0.0000
792 IRRITABLE BOWEL SYNDROME 1 0.0000
793 HYPOACUSIS 2 0.0000
794 POOR QUALITY SLEEP 1 0.0000
795 BALANCE DISORDER 4 0.0000
796 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
797 DIZZINESS 23 0.0000
798 SWELLING FACE 3 0.0000
799 DEVICE DISLOCATION 2 0.0000
800 SEPTIC SHOCK 2 0.0000
801 PRODUCT DOSE OMISSION 3 0.0000
802 INTENTIONAL PRODUCT MISUSE 4 0.0000
803 FEBRILE NEUTROPENIA 3 0.0000
804 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
805 LIVER DISORDER 2 0.0000
806 HEPATOTOXICITY 1 0.0000
807 PANCREATITIS ACUTE 1 0.0000
808 PRODUCT AVAILABILITY ISSUE 1 0.0000
809 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
810 MEMORY IMPAIRMENT 6 0.0000
811 TINNITUS 2 0.0000
812 SKIN DISCOLOURATION 2 0.0000
813 ADVERSE EVENT 4 0.0000
814 NASOPHARYNGITIS 8 0.0000
815 BLOOD CHOLESTEROL INCREASED 2 0.0000
816 SWELLING 4 0.0000
817 BLOOD GLUCOSE INCREASED 8 0.0000
818 ARRHYTHMIA 2 0.0000
819 OCULAR HYPERAEMIA 2 0.0000
820 DYSPHAGIA 4 0.0000
821 PULMONARY EMBOLISM 4 0.0000
822 PRODUCT PRESCRIBING ERROR 1 0.0000
823 BLOOD PRESSURE FLUCTUATION 1 0.0000
824 DIABETIC KETOACIDOSIS 1 0.0000
825 INFECTION 6 0.0000
826 LOCALISED INFECTION 1 0.0000
827 MENTAL IMPAIRMENT 1 0.0000
828 HYPOGLYCAEMIA 2 0.0000
829 FATIGUE 32 0.0000
830 ARTHRALGIA 17 0.0000
831 PRODUCT DOSE OMISSION ISSUE 12 0.0000
832 INJECTION SITE URTICARIA 1 0.0000
833 BRONCHITIS 3 0.0000
834 NAUSEA 32 0.0000
835 EXTRAPYRAMIDAL DISORDER 1 0.0000
836 FLUID RETENTION 2 0.0000
837 CHEST DISCOMFORT 4 0.0000
838 HOSPITALISATION 6 0.0000
839 LOSS OF CONSCIOUSNESS 5 0.0000
840 PERIPHERAL SWELLING 6 0.0000
841 ERECTILE DYSFUNCTION 1 0.0000
842 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
843 INFLAMMATION 2 0.0000
844 DIPLOPIA 1 0.0000
845 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
846 HEADACHE 24 0.0000
847 NERVOUSNESS 2 0.0000
848 MUSCULOSKELETAL PAIN 2 0.0000
849 SPEECH DISORDER 2 0.0000
850 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
851 ARTHRITIS 3 0.0000
852 PANCREATITIS 2 0.0000
853 DEPRESSED MOOD 2 0.0000
854 BRADYCARDIA 2 0.0000
855 PYREXIA 13 0.0000
856 DRUG EFFECT DECREASED 2 0.0000
857 OEDEMA 2 0.0000
858 PALLOR 1 0.0000
859 FALL 12 0.0000
860 PROCEDURAL PAIN 1 0.0000
861 MENTAL STATUS CHANGES 1 0.0000
862 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
863 INFLUENZA 4 0.0000
864 HAEMOPTYSIS 1 0.0000
865 DEMENTIA 1 0.0000
866 DIARRHOEA 23 0.0000
867 BLISTER 2 0.0000
868 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
869 PAIN IN JAW 1 0.0000
870 INTENTIONAL DOSE OMISSION 1 0.0000
871 CONVULSION 2 0.0000
872 HYPERSOMNIA 1 0.0000
873 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
874 PANCREATIC CARCINOMA 1 0.0000
875 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
876 DECREASED APPETITE 8 0.0000
877 DYSSTASIA 1 0.0000
878 COVID-19 6 0.0000
879 PALPITATIONS 4 0.0000
880 ASCITES 1 0.0000
881 PNEUMONIA 11 0.0000
882 LABORATORY TEST ABNORMAL 1 0.0000
883 PSYCHOTIC DISORDER 1 0.0000
884 TACHYCARDIA 3 0.0000
885 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
886 BLOOD POTASSIUM DECREASED 1 0.0000
887 PREMATURE BABY 1 0.0000
888 APHASIA 1 0.0000
889 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
890 STOMATITIS 2 0.0000
891 ILL-DEFINED DISORDER 2 0.0000
892 BLOOD PRESSURE INCREASED 5 0.0000
893 INJECTION SITE RASH 1 0.0000
894 DRUG ADMINISTRATION ERROR 1 0.0000
895 CARDIAC DISORDER 3 0.0000
896 NEUROPATHY PERIPHERAL 3 0.0000
897 METABOLIC ACIDOSIS 1 0.0000
898 WEIGHT INCREASED 7 0.0000
899 CONTUSION 3 0.0000
900 MOVEMENT DISORDER 1 0.0000
901 DRUG INTOLERANCE 3 0.0000
902 BLOOD CREATININE INCREASED 2 0.0000
903 IMPAIRED HEALING 1 0.0000
904 DEVICE DIFFICULT TO USE 2 0.0000
905 BLOOD PRESSURE DECREASED 2 0.0000
906 SYNCOPE 3 0.0000
907 NEOPLASM MALIGNANT 2 0.0000
908 TOXICITY TO VARIOUS AGENTS 5 0.0000
909 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
910 FLUSHING 3 0.0000
911 URINARY TRACT INFECTION 5 0.0000
912 VISION BLURRED 4 0.0000
913 ILLNESS 3 0.0000
914 DELIRIUM 1 0.0000
915 ABDOMINAL DISTENSION 3 0.0000
916 HAEMORRHAGE 3 0.0000
917 MYOCARDIAL INFARCTION 5 0.0000
918 DEVICE MALFUNCTION 2 0.0000
919 LYMPHADENOPATHY 1 0.0000
920 PRODUCT ADHESION ISSUE 1 0.0000
921 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
922 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
923 HYPERGLYCAEMIA 1 0.0000
924 OFF LABEL USE 24 0.0000
925 EYE SWELLING 1 0.0000
926 THROMBOCYTOPENIA 3 0.0000
927 ASTHMA 3 0.0000
928 HOT FLUSH 2 0.0000
929 INTESTINAL OBSTRUCTION 1 0.0000
930 COLITIS 1 0.0000
931 DIABETES MELLITUS 2 0.0000
932 INJECTION SITE PAIN 8 0.0000
933 DISORIENTATION 1 0.0000
934 DRUG INTERACTION 4 0.0000
935 INJECTION SITE BRUISING 2 0.0000
936 DYSPNOEA 14 0.0000
937 LUNG NEOPLASM MALIGNANT 1 0.0000
938 TREATMENT FAILURE 2 0.0000
939 URTICARIA 4 0.0000
940 ABDOMINAL DISCOMFORT 4 0.0000
941 MENTAL DISORDER 1 0.0000
942 DRUG WITHDRAWAL SYNDROME 2 0.0000
943 DEHYDRATION 3 0.0000
944 COLITIS ULCERATIVE 1 0.0000
945 GASTROINTESTINAL DISORDER 2 0.0000
946 NEUTROPENIA 3 0.0000
947 NEPHROLITHIASIS 1 0.0000
948 OROPHARYNGEAL PAIN 2 0.0000
949 ANAEMIA 4 0.0000
950 BLOOD GLUCOSE DECREASED 1 0.0000
951 DYSPEPSIA 2 0.0000
952 AGGRESSION 1 0.0000
953 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
954 ECZEMA 1 0.0000
955 OVERDOSE 4 0.0000
956 ANAPHYLACTIC REACTION 1 0.0000
957 PANCYTOPENIA 1 0.0000
958 RHEUMATOID ARTHRITIS 2 0.0000
959 INCORRECT DOSE ADMINISTERED 4 0.0000
960 SEIZURE 2 0.0000
961 CHILLS 2 0.0000
962 DISEASE PROGRESSION 2 0.0000
963 CATARACT 1 0.0000
964 DISCOMFORT 1 0.0000
965 INJECTION SITE ERYTHEMA 2 0.0000
966 EXPOSURE DURING PREGNANCY 1 0.0000
967 DEVICE EXPULSION 1 0.0000
968 INFUSION RELATED REACTION 1 0.0000
969 INJECTION SITE PRURITUS 1 0.0000
970 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
971 INJECTION SITE SWELLING 1 0.0000
972 DRUG DOSE OMISSION BY DEVICE 1 0.0000
973 INJECTION SITE HAEMORRHAGE 1 0.0000
974 CARDIAC FAILURE 1 0.0000
975 CARDIAC FAILURE CONGESTIVE 1 0.0000
976 DRUG DEPENDENCE 2 0.0000
977 PROSTATE CANCER 1 0.0000
978 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
979 CARDIAC ARREST 1 0.0000
980 CEREBROVASCULAR ACCIDENT 2 0.0000
981 DEATH 10 0.0000
982 PRODUCT STORAGE ERROR 1 0.0000
983 DEVICE ISSUE 1 0.0000
984 HEART RATE INCREASED 1 0.0000
985 HAEMOGLOBIN DECREASED 1 0.0000
986 PLATELET COUNT DECREASED 1 0.0000
987 MALAISE 4 0.0000
988 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000